Literature DB >> 15767514

Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.

Ali B Naini1, Jiesheng Lu, Petra Kaufmann, Richard A Bernstein, Michelangelo Mancuso, Eduardo Bonilla, Michio Hirano, Salvatore DiMauro.   

Abstract

BACKGROUND: The mitochondrial DNA gene encoding subunit 5 of complex I (ND5) has turned out to be a hot spot for mutations associated with mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS) and various overlap syndromes.
OBJECTIVE: To describe a novel mutation in the ND5 gene in a young man man with an overlap syndrome of MELAS and myoclonus epilepsy with ragged-red fibers.
DESIGN: Case report. PATIENT: A 25-year-old man had recurrent strokes, seizures, and myoclonus. His mother also had multiple strokes. A muscle biopsy specimen showed no ragged-red fibers but several strongly succinate dehydrogenase-reactive blood vessels.
RESULTS: Biochemical analysis showed isolated complex I deficiency and molecular analysis revealed a novel heteroplasmic mutation (G13042A) in the ND5 gene.
CONCLUSIONS: These data confirm that ND5 is a genetic hot spot for overlap syndromes, including MELAS and strokelike and myoclonus epilepsy with ragged-red fibers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767514     DOI: 10.1001/archneur.62.3.473

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

Review 1.  Mitochondrial complex I: structure, function and pathology.

Authors:  Rolf J R J Janssen; Leo G Nijtmans; Lambert P van den Heuvel; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

2.  A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes.

Authors:  Ioannis Zaganas; Helen Latsoudis; Eufrosini Papadaki; Pelagia Vorgia; Martha Spilioti; Andreas Plaitakis
Journal:  J Neurol       Date:  2009-02-27       Impact factor: 4.849

Review 3.  Movement disorders in mitochondrial disease.

Authors:  Roula Ghaoui; Carolyn M Sue
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

4.  Mitochondrial genome instability in colorectal adenoma and adenocarcinoma.

Authors:  Luiza F de Araujo; Aline S Fonseca; Bruna R Muys; Jessica R Plaça; Rafaela B L Bueno; Julio C C Lorenzi; Anemari R D Santos; Greice A Molfetta; Dalila L Zanette; Jorge E S Souza; Valeria Valente; Wilson A Silva
Journal:  Tumour Biol       Date:  2015-06-12

5.  MERRF/MELAS overlap syndrome due to the m.3291T>C mutation.

Authors:  Kaiming Liu; Hui Zhao; Kunqian Ji; Chuanzhu Yan
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

6.  Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.

Authors:  M J Blok; L Spruijt; I F M de Coo; K Schoonderwoerd; A Hendrickx; H J Smeets
Journal:  J Med Genet       Date:  2007-04       Impact factor: 6.318

Review 7.  Mitochondrial dysfunction in neurological disorders with epileptic phenotypes.

Authors:  Gábor Zsurka; Wolfram S Kunz
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

8.  A MELAS syndrome family harboring two mutations in mitochondrial genome.

Authors:  Byung-Ok Choi; Jung Hee Hwang; Joonki Kim; Eun Min Cho; Sun Young Cho; Su Jin Hwang; Hyang Woon Lee; Song Ja Kim; Ki Wha Chung
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

9.  The 13042G --> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype.

Authors:  M L Valentino; P Barboni; C Rengo; A Achilli; A Torroni; R Lodi; C Tonon; B Barbiroli; F Fortuna; P Montagna; A Baruzzi; V Carelli
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

10.  Near-identical segregation of mtDNA heteroplasmy in blood, muscle, urinary epithelium, and hair follicles in twins with optic atrophy, ptosis, and intractable epilepsy.

Authors:  Achilles Spyropoulos; Mark Manford; Rita Horvath; Charlotte L Alston; Patrick Yu-Wai-Man; Langping He; Robert W Taylor; Patrick F Chinnery
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.